Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 1
1986 1
1991 1
1994 1
1995 1
1997 2
1998 3
1999 1
2000 1
2002 4
2003 1
2004 5
2005 2
2006 3
2007 2
2008 2
2009 2
2010 3
2011 2
2012 13
2013 8
2014 2
2015 4
2016 7
2017 8
2018 9
2019 7
2020 3
2021 4
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 19109560

90 results

Results by year

Filters applied: . Clear all
Page 1
A randomized controlled trial comparing standard- and low-dose strategies for transfusion of platelets (SToP) to patients with thrombocytopenia.
Heddle NM, Cook RJ, Tinmouth A, Kouroukis CT, Hervig T, Klapper E, Brandwein JM, Szczepiorkowski ZM, AuBuchon JP, Barty RL, Lee KA; SToP Study Investigators of the BEST Collaborative. Heddle NM, et al. Blood. 2009 Feb 12;113(7):1564-73. doi: 10.1182/blood-2008-09-178236. Epub 2008 Dec 24. Blood. 2009. PMID: 19109560 Free article. Clinical Trial.
Pathogen-reduced platelets for the prevention of bleeding.
Estcourt LJ, Malouf R, Hopewell S, Trivella M, Doree C, Stanworth SJ, Murphy MF. Estcourt LJ, et al. Cochrane Database Syst Rev. 2017 Jul 30;7(7):CD009072. doi: 10.1002/14651858.CD009072.pub3. Cochrane Database Syst Rev. 2017. PMID: 28756627 Free PMC article. Review.
Dose of prophylactic platelet transfusions and prevention of hemorrhage.
Slichter SJ, Kaufman RM, Assmann SF, McCullough J, Triulzi DJ, Strauss RG, Gernsheimer TB, Ness PM, Brecher ME, Josephson CD, Konkle BA, Woodson RD, Ortel TL, Hillyer CD, Skerrett DL, McCrae KR, Sloan SR, Uhl L, George JN, Aquino VM, Manno CS, McFarland JG, Hess JR, Leissinger C, Granger S. Slichter SJ, et al. N Engl J Med. 2010 Feb 18;362(7):600-13. doi: 10.1056/NEJMoa0904084. N Engl J Med. 2010. PMID: 20164484 Free PMC article. Clinical Trial.
Pathogen-reduced platelets for the prevention of bleeding.
Butler C, Doree C, Estcourt LJ, Trivella M, Hopewell S, Brunskill SJ, Stanworth S, Murphy MF. Butler C, et al. Cochrane Database Syst Rev. 2013 Mar 28;(3):CD009072. doi: 10.1002/14651858.CD009072.pub2. Cochrane Database Syst Rev. 2013. PMID: 23543569 Updated. Review.
New strategies for the optimal use of platelet transfusions.
Blajchman MA, Slichter SJ, Heddle NM, Murphy MF. Blajchman MA, et al. Hematology Am Soc Hematol Educ Program. 2008:198-204. doi: 10.1182/asheducation-2008.1.198. Hematology Am Soc Hematol Educ Program. 2008. PMID: 19074082
Safety and cost effectiveness of a 10 x 10(9)/L trigger for prophylactic platelet transfusions compared with the traditional 20 x 10(9)/L trigger: a prospective comparative trial in 105 patients with acute myeloid leukemia.
Wandt H, Frank M, Ehninger G, Schneider C, Brack N, Daoud A, Fackler-Schwalbe I, Fischer J, Gäckle R, Geer T, Harms P, Löffler B, Ohl S, Otremba B, Raab M, Schönrock-Nabulsi P, Strobel G, Winter R, Link H. Wandt H, et al. Blood. 1998 May 15;91(10):3601-6. Blood. 1998. PMID: 9572994 Free article. Clinical Trial.
Comparison of the Hemostatic Efficacy of Pathogen-Reduced Platelets vs Untreated Platelets in Patients With Thrombocytopenia and Malignant Hematologic Diseases: A Randomized Clinical Trial.
Garban F, Guyard A, Labussière H, Bulabois CE, Marchand T, Mounier C, Caillot D, Bay JO, Coiteux V, Schmidt-Tanguy A, Le Niger C, Robin C, Ladaique P, Lapusan S, Deconinck E, Rolland C, Foote AM, François A, Jacquot C, Tardivel R, Tiberghien P, Bosson JL; Evaluation of the Efficacy of Platelets Treated With Pathogen Reduction Process (EFFIPAP) Study Group. Garban F, et al. JAMA Oncol. 2018 Apr 1;4(4):468-475. doi: 10.1001/jamaoncol.2017.5123. JAMA Oncol. 2018. PMID: 29392283 Free PMC article. Clinical Trial.
90 results